[Potential of imaging in the clinical routine : Focus on cardiovascular MRI].
Authors
Affiliations (11)
Affiliations (11)
- Medizinische Klinik III, Kardiologie, Helios Universitätsklinikum Wuppertal, Universität Witten/Herdecke, Wuppertal, Deutschland. [email protected].
- Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen und Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Standort Niedersachsen, Göttingen, Deutschland.
- Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center und Harvard Medical School, Boston, USA.
- Klinik für Herz- und Kreislauferkrankungen, Abteilung für Elektrophysiologie, Deutsches Herzzentrum, Technische Universität München (TUM), München, Deutschland.
- Klinik für Kardiologie und Angiologie, GRN-Klinik Weinheim, Weinheim, Deutschland.
- Bildgebungszentrum Weinheim, Hector Stiftung, Weinheim, Deutschland.
- FORUM Medizin, Kardiologie, Rosdorf, Deutschland.
- Charite, Universitätsmedizin Berlin, Experimental and Clinical Research Center, Gemeinsame Einrichtung von Charite und Max-Delbrück-Zentrum, Klinik für Kardiologie und Nephrologie, HELIOS-Klinikum Berlin-Buch, Berlin, Deutschland.
- DZHK (German Centre for Cardiovascular Research), partner site, Berlin, Deutschland.
- Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Chariteplatz 1, Berlin, Deutschland.
- Deutsches Herzzentrum der Charité Standort Mitte, Chariteplatz 1, Berlin, Deutschland.
Abstract
Cardiac magnetic resonance imaging (CMR) provides decisive advantages, particularly in coronary heart disease, myocarditis and cardiomyopathy. It accurately detects ischemia, scarring, edema and microvascular disorders, enables reliable risk stratification and supports treatment decisions such as revascularization or medication adjustments. Modern quantitative perfusion methods and artificial intelligence (AI)-based analyses further increase the diagnostic accuracy. In inflammatory myocardial and pericardial diseases, CMR using mapping techniques and late gadolinium enhancement (LGE) forms the basis for differentiated diagnostics and estimation of the prognosis. It also enables a precise etiological classification and provides prognostically relevant parameters in cases of hypertrophic, dilated, arrhythmogenic and restrictive cardiomyopathies. In the diagnostics of valvular diseases and the planning of interventional procedures and cardiac tumors, CMR provides essential additional information and demonstrates a high sensitivity and specificity. New techniques such as quantitative 4‑dimensional (4D) flow measurements, high-resolution 3D imaging and electrocardiograph (ECG)-independent scans will further increase its value. Due to the increasing number of CMR examinations, standardized procedures, qualified personnel and structured training programs are essential to ensure a high quality of care in the long term.